210 related articles for article (PubMed ID: 33940542)
1. Prognostic index for estimating the survival benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: A real-world validation study.
Zhang CC; Hou RP; Xia WY; Zeng WQ; Liu J; Wang JM; Lv CX; Luo QQ; Zhao H; Yu W; Zhang Q; Zhu ZF; Cai XW; Feng W; Fu XL
Lung Cancer; 2021 Jun; 156():100-108. PubMed ID: 33940542
[TBL] [Abstract][Full Text] [Related]
2. A decision support framework for postoperative radiotherapy in patients with pathological N2 non-small cell lung cancer.
Zhang CC; Yu W; Zhang Q; Cai XW; Feng W; Fu XL
Radiother Oncol; 2022 Aug; 173():313-318. PubMed ID: 35764192
[TBL] [Abstract][Full Text] [Related]
3. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.
Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Jiang H; Ming Wang J; Li B
Radiol Oncol; 2020 Dec; 55(1):66-76. PubMed ID: 33885242
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy.
Moretti L; Yu DS; Chen H; Carbone DP; Johnson DH; Keedy VL; Putnam JB; Sandler AB; Shyr Y; Lu B
Oncologist; 2009 Nov; 14(11):1106-15. PubMed ID: 19897534
[TBL] [Abstract][Full Text] [Related]
5. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
6. Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.
Brandt WS; Yan W; Leeman JE; Tan KS; Park BJ; Adusumilli PS; Bott MJ; Molena D; Isbell J; Chaft J; Rimner A; Jones DR
Ann Thorac Surg; 2018 Sep; 106(3):848-855. PubMed ID: 29807005
[TBL] [Abstract][Full Text] [Related]
7. Survival Patterns for Patients with Resected N2 Non-Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach.
Deng W; Xu T; Xu Y; Wang Y; Liu X; Zhao Y; Yang P; Liao Z
J Thorac Oncol; 2018 Dec; 13(12):1968-1974. PubMed ID: 30194035
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.
Mikell JL; Gillespie TW; Hall WA; Nickleach DC; Liu Y; Lipscomb J; Ramalingam SS; Rajpara RS; Force SD; Fernandez FG; Owonikoko TK; Pillai RN; Khuri FR; Curran WJ; Higgins KA
J Thorac Oncol; 2015 Mar; 10(3):462-71. PubMed ID: 25384064
[TBL] [Abstract][Full Text] [Related]
9. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
[TBL] [Abstract][Full Text] [Related]
10. Patient prognostic scores and association with survival improvement offered by postoperative radiotherapy for resected IIIA/N2 non-small cell lung cancer: A population-based study.
Xu L; Xie HN; Chen XK; Bi N; Qin JJ; Li Y
Thorac Cancer; 2021 Mar; 12(6):760-767. PubMed ID: 33481353
[TBL] [Abstract][Full Text] [Related]
11. Postoperative intensity-modulated radiation therapy reduces local recurrence and improves overall survival in III-N2 non-small-cell lung cancer: A single-center, retrospective study.
Wei W; Zhou J; Zhang Q; Liao DH; Liu QD; Zhong BL; Liang ZB; Zhang YC; Jiang R; Liu GY; Xu CY; Li Zhou H; Zhu SY; Yang N; Jiang W; Liu ZG
Cancer Med; 2020 Apr; 9(8):2820-2832. PubMed ID: 32100444
[TBL] [Abstract][Full Text] [Related]
12. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
Urban D; Bar J; Solomon B; Ball D
J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
[TBL] [Abstract][Full Text] [Related]
13. Uncertain resection of highest mediastinal lymph node positive among pN2 non-small cell lung cancer patients: survival analysis of postoperative radiotherapy and driver gene mutations.
Deng Q; Wang H; Xiu W; Tian X; Gong Y
Jpn J Radiol; 2023 May; 41(5):551-560. PubMed ID: 36484979
[TBL] [Abstract][Full Text] [Related]
14. Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA-N2 resected non-small cell lung cancer.
Jin X; Chen D; Shen Y; Shu J; Sang Y; Yang W; Duan S; Chen Y
Thorac Cancer; 2022 Oct; 13(19):2767-2775. PubMed ID: 36054738
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy.
Fan C; Gao S; Hui Z; Liang J; Lv J; Wang X; He J; Wang L
Radiat Oncol; 2013 Dec; 8():286. PubMed ID: 24321392
[TBL] [Abstract][Full Text] [Related]
16. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
[TBL] [Abstract][Full Text] [Related]
17. Effects of Postoperative Radiotherapy on Survival of Patients With Stage IIIA Resected Non-Small Cell Lung Cancer: Analysis of the SEER Database.
Gao F; Li N; Xu Y; Yang G
J Natl Compr Canc Netw; 2020 Jun; 18(6):718-727. PubMed ID: 32502986
[TBL] [Abstract][Full Text] [Related]
18. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
[TBL] [Abstract][Full Text] [Related]
19. Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution.
Dai H; Hui Z; Ji W; Liang J; Lu J; Ou G; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; He J; Wang L
Oncologist; 2011; 16(5):641-50. PubMed ID: 21482587
[TBL] [Abstract][Full Text] [Related]
20. Machine learning to refine prognostic and predictive nodal burden thresholds for post-operative radiotherapy in completely resected stage III-N2 non-small cell lung cancer.
Zarinshenas R; Ladbury C; McGee H; Raz D; Erhunmwunsee L; Pathak R; Glaser S; Salgia R; Williams T; Amini A
Radiother Oncol; 2022 Aug; 173():10-18. PubMed ID: 35618098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
